… Adkins-Jackson, PhD, MPH, is a Michael J. Fox Foundation Research Fellow in partnership with the Community Access, Recruitment and Engagement (CARE) Research Center at Massachusetts General Hospital. To date, most Parkinson’s disease (PD) research has not been fully representative of all people who …

… patients have unrealistic expectations about the pace of research advances and that such expectations interfere with … was to compare expert expectations about the timing of research milestone attainment with those of patients who follow Parkinson's disease (PD) research. Methods:  Patients with PD and experts were asked …

… Health (NIH). Join us to urge Congress to increase critical research funding. Take Action In response to the budget … Health (NIH). The NIH is the primary driver of biomedical research progress, for the benefit of the health of … Association, The Michael J. Fox Foundation for Parkinson’s Research and The Parkinson’s Foundation collectively ask …

… molecular level, a necessary starting point for the search into a novel therapeutic strategy. Study Design: Nanobodies … nanobodies that bind LRRK2 in a specific manner. Impact on Diagnosis / Treatment of Parkinson's disease / Next Steps … LRRK2. These nanobodies are interesting tools for further research into LRRK2 and we can use them as probes to monitor …

… of the Michael J. Fox Foundation for Parkinson’s Research did so because they felt an urgency about finding a … he knew he wanted to keep its efforts tightly focused on research. “One of the reasons we focused on research was … foundation in 2000, following the public disclosure of his diagnosis in 1991 at age 30 of young-onset Parkinson’s …

… This grant builds upon the research from a prior grant: Regulated GDNF Gene Therapy: a … for DD-regulated GDNF in vivo. This will give us insight into the possibility of the system for dosing the gene … of toxicity of the DD-system in vivo. Importance of This Research for the Development of a New PD Therapy:  The …